
Check out Investor Copilot custom GPT, which lets you enjoy ChatGPT functionality with recent financial information
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
Conversationally interact with ChatGPT to now analyze updated prices, technical indicators, financial statements, macro-economic/company news & more for Stocks, ETFs & Cryptos
[BPMC] Blueprint Medicines Corp - Long-Term Investments
Data updated 2024-Mar-24 (Sunday)Note: Detailed Statistics for Long-Term Investments in Balance Sheet for Blueprint Medicines Corp [NASDAQ:BPMC] with frequency distribution chart that analyze trends & history . Long-Term Investments include real estate, securities etc. that the Company plans to hold for longer than a year. View Balance Sheet for broader context
Share
Quarterly Long-Term Investments values for Blueprint Medicines Corp are rounded to enhance readability
2023-Dec | 2023-Sep | 2023-Jun | 2023-Mar | 2022-Dec | 2022-Sep | |
---|---|---|---|---|---|---|
Long-Term Investments | 94.6 M | 152 M | 148 M | 172 M | 166 M | 89 M |
Sequential Quarter Growth | -37.8% | +2.7% | -14.0% | +3.6% | +86.5% | -10.1% |
Quarter-on Quarter Growth | -43.0% | +70.8% | +49.5% | -44.9% | -70.5% | -85.1% |
Annual Long-Term Investments values for Blueprint Medicines Corp are rounded to enhance readability
2023-Dec | 2022-Dec | 2022-Jan | 2021-Jan | 2020-Jan | 2019-Jan | |
---|---|---|---|---|---|---|
Long-Term Investments | 94.6 M | 166 M | 166 M | 563 M | 683 M | 70 M |
Year-on-Year Growth | -43.0% | 0.0% | -70.5% | -17.6% | +875.7% | +Inf% |
2-yr CAGR | -24.5% | -45.7% | -50.7% | +183.6% | +13.8% | |
3-yr CAGR | -44.8% | -37.6% | +33.4% | +132.9% | ||
4-yr CAGR | -39.0% | +24.1% | +79.6% | |||
5-yr CAGR | +6.2% | +25.2% |
Frequency distribution of quarterly Long-Term Investments values from 2015-Mar-31 grouped into buckets. Latest Long-Term Investments value is 94.6 Million as of 2023-Dec-31
Subsequent stock performance post earnings date till next announcement for Blueprint Medicines Corp mapped with quarterly Long-Term Investments values reported at that time. Most recent value denoted with star
Select frequency and calculation type for Long-Term Investments above for vertical axis in scatter chart. Additionally choose type of performance for horizontal axis
Bayesian (Conditional Probability) analysis for Blueprint Medicines Corp with subsequent post-earnings performance given Long-Term Investments values. Analysis uses quarterly data and subsequent absolute performance. Most recent quarter is denoted with a star and corresponding partial performance is excluded from calculations
Underperform (absolute perf.) | Outperform (absolute perf.) | |
---|---|---|
Long-Term Investments - Low | 48% | 52% |
Long-Term Investments - Medium | 51% | 49% |
Long-Term Investments - High | 56% | 44% |
Long-Term Investments (Sequential growth %) - Low | 44% | 56% |
Long-Term Investments (Sequential growth %) - Medium | 73% | 27% |
Long-Term Investments (Sequential growth %) - High | 30% | 70% |
Long-Term Investments (QoQ growth %) - Low | 68% | 32% |
Long-Term Investments (QoQ growth %) - Medium | 68% | 32% |
Long-Term Investments (QoQ growth %) - High | 51% | 49% |
Related to Blueprint Medicines Corp
Information for Blueprint Medicines Corp
Current Detail : Recent daily/monthly performance & benchmark comparison
Historical Detail : Historical performance & related information using Time Machine
Financial Statements : Analyze Income Statement, Balance Sheet & Cashflow Statement and also compare with peers Currently Viewing
Bayesian Statement Classifier : Investigate historical financial statements to make probabalistic predictions using Artificial Intelligence
Anomaly Detection : Investigate unusual recent performance & technicals with historical context using AI
Historical Seasonality : Seasonal performance by calendar months
Technical History : Popular Technical indicator trends (RSI, MACD etc.)
Metric Deciles : Contextualizing recent performance & technical levels into historical decile buckets
Dollar Cost Averaging : Dollar Cost Average (DCA) over time in your portfolio
Moving Averages : Key Simple & Exponential Moving Averages
Historical Analogues : Insights from closest historical matches to recent performance using Artificial Intelligence
Chart Pattern Matching : Insights from similar historical charts to recent chart using Artificial Intelligence
News Stories : News stories on 2025-Jul-08 on Google
SEC Reports : Quarterly reports around 2025-Jul-08 on SEC Edgar
Compare Blueprint Medicines Corp with other assets
Market Performance : Recent performance across covered assets
Historical Performance : Prior & Subsequent performance across assets on a historical date
Market Technicals : Technical indicator levels across covered assets
Market Seasonality : Seasonal performance by calendar months across covered assets
Pair Correlations : Performance Correlations with other assets
Beta : Volatility relative to the broad market
Performance Comparison : Visually compare/benchmark performance with other assets over time
Side-by-Side Comparison : Contrast with other assets over time in a side-by-side presentation
Sector : Health Care sector performance which includes Blueprint Medicines Corp
Industry : Biotechnology industry performance which includes Blueprint Medicines Corp